uchibori ryosuke

FacultyDivisionofImmuno-Gene&CellTherapy(TakaraBio)
Job titleAssistant ProfessorWeb site

Profile

Research Areas

  • Oncology / Tumor immunology
  • Clinical internal medicine / Hematology

Academic Societies

  • JAPAN SOCIETY OF GENE THERAPY
  • THE JAPANESE CANCER ASSOCIATION
  • THE JAPANESE SOCIETY OF HEMATOLOGY
  • AMERICAN SOCIETY OF GENE & CELL THERAPY
Display all
Academic Societiesclose
  • JAPAN SOCIETY OF GENE THERAPY
  • THE JAPANESE CANCER ASSOCIATION
  • THE JAPANESE SOCIETY OF HEMATOLOGY
  • AMERICAN SOCIETY OF GENE & CELL THERAPY

Research Activities

Papers(paper)

  • Cancer gene therapy using mesenchymal stem cells.
    Uchibori R, Tsukahara T, Ohmine K, Ozawa K
    International journal of hematology 99(4) 377-382 Apr. 2014
  • Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T, Kanazawa T, Mizukami H, Uchibori R, Tsukahara T, Urabe M, Kume A, Misawa K, Carey TE, Suzuki M, Ichimura K, Ozawa K
    Cancer science 105(1) 72-80 Jan. 2014
  • CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.
    Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T, Urabe M, Mizukami H, Kume A, Nakamura M, Mineno J, Takesako K, Riviere I, Sadelain M, Brentjens R, Ozawa K
    Biochemical and biophysical research communications 438(1) 84-89 Aug. 2013
  • NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites.
    Uchibori R, Tsukahara T, Mizuguchi H, Saga Y, Urabe M, Mizukami H, Kume A, Ozawa K
    Cancer research 73(1) 364-372 Jan. 2013
  • [Mesenchymal stem cells (MSCs) as a platform for cancer gene therapy].
    Uchibori R, Ozawa K
    [Rinsho ketsueki] The Japanese journal of clinical hematology 51(11) 1641-1646 Nov. 2010
  • Establishment and characterization of transplantable, luminescence labeled rat renal cell carcinoma cell lines.
    Kobayashi M, Murakami T, Uchibori R, Chun NA, Kobayashi E, Morita T, Ozawa K
    The Journal of urology 183(5) 2029-2035 May 2010
  • Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes.
    Okada T, Nonaka-Sarukawa M, Uchibori R, Kinoshita K, Hayashita-Kinoh H, Nitahara-Kasahara Y, Takeda S, Ozawa K
    Human gene therapy 20(9) 1013-1021 Sep. 2009
  • Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K
    The journal of gene medicine 11(5) 373-381 May 2009
  • Cell and gene therapy using mesenchymal stem cells (MSCs).
    Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A
    Journal of autoimmunity 30(3) 121-127 May 2008
  • Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats.
    Ito T, Okada T, Mimuro J, Miyashita H, Uchibori R, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Sakata Y, Shimada K, Ozawa K
    Hypertension 50(3) 531-536 Sep. 2007
Display all
Papers(paper)close
  • Cancer gene therapy using mesenchymal stem cells.
    Uchibori R, Tsukahara T, Ohmine K, Ozawa K
    International journal of hematology 99(4) 377-382 Apr. 2014
  • Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T, Kanazawa T, Mizukami H, Uchibori R, Tsukahara T, Urabe M, Kume A, Misawa K, Carey TE, Suzuki M, Ichimura K, Ozawa K
    Cancer science 105(1) 72-80 Jan. 2014
  • CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.
    Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T, Urabe M, Mizukami H, Kume A, Nakamura M, Mineno J, Takesako K, Riviere I, Sadelain M, Brentjens R, Ozawa K
    Biochemical and biophysical research communications 438(1) 84-89 Aug. 2013
  • NF-κB activity regulates mesenchymal stem cell accumulation at tumor sites.
    Uchibori R, Tsukahara T, Mizuguchi H, Saga Y, Urabe M, Mizukami H, Kume A, Ozawa K
    Cancer research 73(1) 364-372 Jan. 2013
  • [Mesenchymal stem cells (MSCs) as a platform for cancer gene therapy].
    Uchibori R, Ozawa K
    [Rinsho ketsueki] The Japanese journal of clinical hematology 51(11) 1641-1646 Nov. 2010
  • Establishment and characterization of transplantable, luminescence labeled rat renal cell carcinoma cell lines.
    Kobayashi M, Murakami T, Uchibori R, Chun NA, Kobayashi E, Morita T, Ozawa K
    The Journal of urology 183(5) 2029-2035 May 2010
  • Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes.
    Okada T, Nonaka-Sarukawa M, Uchibori R, Kinoshita K, Hayashita-Kinoh H, Nitahara-Kasahara Y, Takeda S, Ozawa K
    Human gene therapy 20(9) 1013-1021 Sep. 2009
  • Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.
    Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A, Ozawa K
    The journal of gene medicine 11(5) 373-381 May 2009
  • Cell and gene therapy using mesenchymal stem cells (MSCs).
    Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, Kikuchi Y, Ito T, Okada T, Urabe M, Mizukami H, Kume A
    Journal of autoimmunity 30(3) 121-127 May 2008
  • Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats.
    Ito T, Okada T, Mimuro J, Miyashita H, Uchibori R, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Sakata Y, Shimada K, Ozawa K
    Hypertension 50(3) 531-536 Sep. 2007
  • Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Ito T, Okada T, Miyashita H, Nomoto T, Nonaka-Sarukawa M, Uchibori R, Maeda Y, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Shimada K, Ozawa K
    Circulation research 101(7) 734-741 Sep. 2007
  • Characterization of a novel oncogenic K-ras mutation in colon cancer.
    Akagi K, Uchibori R, Yamaguchi K, Kurosawa K, Tanaka Y, Kozu T
    Biochemical and biophysical research communications 352(3) 728-732 Jan. 2007
  • A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells.
    Okada T, Uchibori R, Iwata-Okada M, Takahashi M, Nomoto T, Nonaka-Sarukawa M, Ito T, Liu Y, Mizukami H, Kume A, Kobayashi E, Ozawa K
    Molecular therapy : the journal of the American Society of Gene Therapy 13(4) 738-746 Apr. 2006
  • Large-scale production of recombinant viruses by use of a large culture vessel with active gassing.
    Okada T, Nomoto T, Yoshioka T, Nonaka-Sarukawa M, Ito T, Ogura T, Iwata-Okada M, Uchibori R, Shimazaki K, Mizukami H, Kume A, Ozawa K
    Human gene therapy 16(10) 1212-1218 Oct. 2005

Papers(other)

  • Mesenchymal stem cells (MSCs) as a platform for cancer gene therapy
    UCHIBORI Ryosuke
    The Japanese journal of clinical hematology 51(11) 1641-1646 Nov. 2010
Display all
Papers(other)close
  • Mesenchymal stem cells (MSCs) as a platform for cancer gene therapy
    UCHIBORI Ryosuke
    The Japanese journal of clinical hematology 51(11) 1641-1646 Nov. 2010


Copyright c MEDIA FUSION Co.,Ltd. All rights reserved.